Skip to main content
Navigate Up
Sign In
 

MS/Neuroimmunology

Clinical Research



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

Search for: view all

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator PRA
12-0968 Rocky Mountain Multiple Sclerosis Center (RMMSC) Biorepository for the Study of Neuroimmunological Disorders Alvarez, Enrique, MD Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
Determining the Effectiveness of early Intensive Versus Escalation approaches for the treatment of Relapsing-Remitting Multiple Sclerosis (DELIVERMS). Alvarez, Enrique, MD Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
16-2527 An open-label, single-arm study to evaluate the effectiveness and safety of ocrelizumab in patients with early stage relapsing remitting multiple sclerosis. Alvarez, Enrique, MD Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
15-1194 A Phase II, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Multi-Dose Intravitreal Injections to Subjects With Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NAION) Bennett, Jeffrey L., MD, PhD Neurology, Research Partners
303-724-4644
Eligibility and Information
17-1884 Risk factors in Early Multiple Sclerosis Corboy, John R., MD Neurology, Research Partners
303-724-4644
Eligibility and Information
15-2388 Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS) (DISCOMS) Corboy, John R., MD Neurology, Research Partners
303-724-4644
Eligibility and Information
08-0613 The role of TH40 cell in Multiple Sclerosis and Type 1 Diabetes Corboy, John R., MD Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
09-0952 Rocky Mountain MS Center Tissue Bank Corboy, John R., MD Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
18-0179 Comparative Effectiveness of an Exercise Intervention Delivered via Telerehabilitation and Conventional Mode of Delivery Hebert, Jeffrey, P.T., Ph.D Neurology, Research Partners
303-724-4644
Eligibility and Information
16-0156 Natalizumab for Prevention of Post-Partum Relapses in Patients with Multiple Sclerosis Schreiner, Teri L., MD, MPH Neurology, Research Partners
303-724-4644
Eligibility and Information
12-1084 Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Schreiner, Teri L., MD, MPH Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
A 3-Arm, Multicenter, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment Schreiner, Teri L., MD, MPH Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
12-1102 Pediatric Multiple Sclerosis and other Demyelinating Diseases Database (PeMSDD Database) Schreiner, Teri L., MD, MPH Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
16-2178 Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) (POINT) Vollmer, Timothy L., MD Neurology, Research Partners
303-724-4644
Eligibility and Information
Comparative Effects of Glatiramer Acetate and BG0012 on lymphocyte survival and metabolism Vollmer, Timothy L., MD
Greg Owens, PhD
Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information
18-1262 A phase iiib, open-label study to evaluate the safety and tolerability of shorter infusions of ocrelizumab in patients with primary progressive and relapsing multiple sclerosis Vollmer, Timothy L., MD
Neurology, Research Partners
303-724-4644
Please contact PRA for eligibility and information